Literature DB >> 19575248

Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.

L Dales1, W Ferris, K Vandemheen, S D Aaron.   

Abstract

We identified double and triple antibiotic combinations effective against biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa sampled from cystic fibrosis (CF) patients undergoing acute pulmonary exacerbations. Sputum bacteria from 110 CF patients were grown as biofilms. Combination antibiotic susceptibility testing was used to test 94 double and triple antibiotic combinations. Biofilm-grown bacterial isolates were less susceptible to antibiotic combinations compared to the same bacterial isolates grown planktonically (P < 0.001). Fifty-nine percent of biofilm-grown B. cepacia isolates and 29% of P. aeruginosa isolates were resistant to all double antibiotic combinations tested. Triple antibiotic combinations were more effective than double antibiotic combinations against biofilms (P < 0.0001). For P. aeruginosa biofilms, the addition of azithromycin or rifampin to otherwise effective antibiotic combinations was frequently associated with antagonism. Bacterial biofilms of CF organisms are highly resistant to antibiotics. This study identified potentially effective antibiotic combinations to guide the empirical treatment of CF pulmonary exacerbations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575248     DOI: 10.1007/s10096-009-0774-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

2.  The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms.

Authors:  H Ceri; M E Olson; C Stremick; R R Read; D Morck; A Buret
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

3.  Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.

Authors:  E Caraher; G Reynolds; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

4.  Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

Authors:  Dominic Hill; Barbara Rose; Aniko Pajkos; Michael Robinson; Peter Bye; Scott Bell; Mark Elkins; Barbara Thompson; Colin Macleod; Shawn D Aaron; Colin Harbour
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.

Authors:  Shawn D Aaron; Wendy Ferris; Karam Ramotar; Katherine Vandemheen; Francis Chan; Raphael Saginur
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Wendy Ferris; Dean Fergusson; Elizabeth Tullis; David Haase; Yves Berthiaume; Neil Brown; Pearce Wilcox; Veronica Yozghatlian; Peter Bye; Scott Bell; Francis Chan; Barbara Rose; Alphonse Jeanneret; Anne Stephenson; Mary Noseworthy; Andreas Freitag; Nigel Paterson; Steve Doucette; Colin Harbour; Michel Ruel; Noni MacDonald
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

7.  Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms.

Authors:  Robert Slinger; Francis Chan; Wendy Ferris; Sau-Wai Yeung; Melissa St Denis; Isabelle Gaboury; Shawn D Aaron
Journal:  Diagn Microbiol Infect Dis       Date:  2006-06-12       Impact factor: 2.803

8.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.

Authors:  P K Singh; A L Schaefer; M R Parsek; T O Moninger; M J Welsh; E P Greenberg
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

9.  Clinical and environmental Burkholderia strains: biofilm production and intracellular survival.

Authors:  Dianella Savoia; Mario Zucca
Journal:  Curr Microbiol       Date:  2007-04-24       Impact factor: 2.188

10.  Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice.

Authors:  Nadine Hoffmann; Baoleri Lee; Morten Hentzer; Thomas Bovbjerg Rasmussen; Zhijun Song; Helle Krogh Johansen; Michael Givskov; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

View more
  15 in total

Review 1.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

2.  Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.

Authors:  Silvia M Caceres; Kenneth C Malcolm; Jennifer L Taylor-Cousar; David P Nichols; Milene T Saavedra; Donna L Bratton; Samuel M Moskowitz; Jane L Burns; Jerry A Nick
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

3.  Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.

Authors:  Kitty Wu; Yvonne C W Yau; Larissa Matukas; Valerie Waters
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Refractory Burkholderia cepacia bacteraemia from a consolidation pneumonia lasting more than 7 weeks, successfully treated with systemic antibiotics and nebulised meropenem.

Authors:  Bryan Albert Lim; Adelaine Lopez; Joseph Adrian Buensalido
Journal:  BMJ Case Rep       Date:  2019-08-02

5.  In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.

Authors:  Qianru Yu; Edward F Griffin; Sophie Moreau-Marquis; Joseph D Schwartzman; Bruce A Stanton; George A O'Toole
Journal:  J Antimicrob Chemother       Date:  2012-07-26       Impact factor: 5.790

6.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

7.  A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.

Authors:  Suman S Karanth; Hariharan Regunath; Kiran Chawla; Mukhyaprana Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-02

8.  Sustained Pulmonary Delivery of a Water-Soluble Antibiotic Without Encapsulating Carriers.

Authors:  Winston Ong; Pawel Nowak; Yen Cu; Lisa Schopf; James Bourassa; Elizabeth Enlow; Samuel M Moskowitz; Hongming Chen
Journal:  Pharm Res       Date:  2015-10-27       Impact factor: 4.200

9.  Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants.

Authors:  Sílvia A Sousa; Christian G Ramos; Jorge H Leitão
Journal:  Int J Microbiol       Date:  2010-08-03

10.  Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing.

Authors:  Helmy Haja Mydin; Paul A Corris; Audrey Nicholson; John D Perry; Gerard Meachery; Emma C L Marrs; Steven Peart; Christine Fagan; James L Lordan; Andrew J Fisher; Frances K Gould
Journal:  J Transplant       Date:  2012-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.